Schedule 13G ownership disclosure

Opexa Therapeutics, Inc.

Security class unavailable · CUSIP: 68372T202

Event date: 2013-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-14-330089
Form type
SC 13G/A
Filer
Acer Therapeutics Inc.
CIK
CIK 1069308
Filed
Sep 03, 2014
Reporting period
Dec 31, 2013
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub